Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) PROVIDES AN OPERATIONAL UPDATE

nDatalyze Corp. has provided an operational update. The corporation has completed its gathering of marketing statistics from California and New York states for the consumer application (business to consumer) of YMI. The corporation continues its search for a qualified third party to conduct a clinical trial and/or peer review of the B2B (business-to-business) aspect of the YMI application, which aspect has been expanded to include first responders, law enforcement, government and regulatory agencies, security forces, airlines, and insurance risk assessment markets. The purpose of this process is to determine economic success probabilities of the B2C versus B2B aspects of the YMI predictive mental health application. The corporation will provide updates as the search progresses.

About YMI

YMI uses evidence-based, objective data from whole-life experiences to predict individual mental states over time and applies this knowledge toward a fuller understanding of how mental health develops and to improve mental well-being. After registering at ymihealth.ca, users gain access to a private, in-depth survey that applies machine learning using a person's genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle. Upon completion of the questionnaire YMI generates a personalized graphic report predicting a person's predisposition toward seven mental conditions, including anxiety, depression, posttraumatic stress disorder, obsessive-compulsive disorder, alcoholism and personality disorders, both current and forward in time. The downloadable report may be used for reference as the user considers changes to his or her lifestyle that may help improve his or her mental well-being and mental health journey.

About nDatalyze Corp.

nDatalyze generates technology-based, health-related solutions. Its machine-learning-processed, on-line consumer mental health application, known as YMI, is based on the corporation's proprietary reference database consisting of greater than 1,200 biometric records complete with associated electroencephalogram (EEG) data. YMI has only recently begun its initial staged launch; and, accordingly, the corporation cannot accurately predict if or when this application will become a profit generator.

We seek Safe Harbor.